Amg. Verhagen et al., Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations, KIDNEY INT, 56(1), 1999, pp. 222-231
Background. Chronic nitric oxide synthase (NOS) inhibition results in hyper
tension, proteinuria, and renal morphological changes. Continuous angiotens
in II (Ang II) blockade prevents these effects, suggesting an essential rol
e of Ang II, However, it is not known whether renal Ang II concentrations a
re primarily increased or whether the scarcity of NO allows normal concentr
ations of Ang II to cause these detrimental effects. Therefore, we measured
renal Ang II concentrations before and during the development of renal dam
age.
Methods. Group 1 served as controls. Groups 2 through 5 received the NOS in
hibitor N omega-nitro-L-arginine (L-NNA: 40 mg/kg/day) for 4, 7, 14, and 21
days, respectively. Systolic blood pressure (SBP), proteinuria. glomerular
filtration rate (GFR). and renal and blood Ang II were measured. In a sepa
rate experiment, rats were treated with L-NNA + the Ang II AT(1) receptor b
locker losartan to determine the functional effects of endogenous Ang II du
ring chronic NOS inhibition.
Results. L-NNA treatment resulted in an increase in SEP from day 4 (161 +/-
4 vs. 135 +/- 4 mm Hg in control, P < 0.05) to day 21 (230 +/- 9 mm Hg). G
FR was decreased from day 4 (1.9 +/- 0.2 vs. 2.5 +/- 0.2 ml/min in control,
P < 0.05) to day 21 (1.2 +/- 0.2 ml/min). Proteinuria was increased from d
ay 14 (85 +/- 14 vs. 6 +/- 1 mg/day in control, P < 0.05) to day 21 (226 +/
- 30 mg/day). L-NNA treatment during four days resulted in a significant de
crease in renal Ang II (183 +/- 32 vs. 454 +/- 40 fmol/g in control, P < 0.
05). On day 7, 14, and 21, renal Ang II was not significantly different fro
m the control. Blood Ang II was not significantly different from the contro
l on days 4,7, and 14 but was significantly increased after 21 days of L-NN
A treatment (215 +/- 35 vs. 78 +/- 13 fmol/ml in control, P < 0.05). Ang II
type-1 (AT(1)) receptor blockade prevented the severe renal injury and hyp
ertension induced by chronic NOS inhibition.
Conclusions. Losartan-sensitive renal damage caused by chronic NOS inhibiti
on does not involve increased renal Ang II concentrations. This suggests th
at the detrimental effects of endogenous Ang II are increased during chroni
c NOS inhibition. Thus, when NO levels are low, normal Ang II concentration
s can cause renal injury and hypertension.